FIELD: medicine; pharmacology.
SUBSTANCE: invention can be applied for treatment of asthma and associated disorders, specifically for treatment of chronic obstructive lungs disease. This composition contains specific anticholinergic agents, antagonists of β-2 and corticosteroids.
EFFECT: favourable and improved asthma treatment.
33 cl, 43 ex
| Title | Year | Author | Number |
|---|---|---|---|
| CYLINDER FOR DELIVERY OF PHARMACEUTICAL COMPOSITION, DOSING INHALATOR | 1992 |
|
RU2179037C2 |
| AEROSOL MEDICINAL COMPOSITION FOR INHALATION (VARIANTS) | 1992 |
|
RU2098082C1 |
| AEROSOL PHARMACEUTICAL COMPOSITION, A METHOD OF TREATMENT OF PATIENTS WITH RESPIRATORY DISEASES | 1992 |
|
RU2129424C1 |
| PHARMACEUTICAL AEROSOL COMPOSITION | 2009 |
|
RU2565438C2 |
| TROVENTOL-BASED COMPOSITION | 2006 |
|
RU2457832C2 |
| MEDICINAL AEROSOL COMPOSITIONS | 2002 |
|
RU2294737C2 |
| COMBINATIONS CONTAINING ANTIMUSCARINE AGENTS AND CORTICOSTEROIDS | 2005 |
|
RU2385156C2 |
| METHOD FOR PREPARING METERED DOSE SPRAYED INHALER FOR TREATING RESPIRATORY DISEASE | 2012 |
|
RU2582218C2 |
| COMPOSITIONS FOR RESPIRATORY DELIVERY OF ACTIVE SUBSTANCES AND METHODS AND SYSTEMS CONNECTED THEREWITH | 2010 |
|
RU2580315C2 |
| SPECIFIC GLYCOCORTICOSTEROID COMPOUND WITH ANTIINFLAMMATORY EFFECT | 2004 |
|
RU2359973C2 |
